U.S. phase II trial explores use of Velexbru in primary central nervous system lymphoma July 19, 2021
Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA July 19, 2021
KRIBB-11 controls molecular pathways with potential for therapeutic strategy for glioblastoma July 16, 2021